Background
A.F.H. was admitted to the Colorado Mental Health Hospital in Pueblo (CMHHIP) after being found incompetent to proceed on pending criminal charges. His treating psychiatrist, Dr. Hareesh Pillai, diagnosed him with an unspecified mood disorder manifesting as disorganized thinking, agitation, delusions, and paranoia. A.F.H. had a lengthy history of psychiatric hospitalizations, mental health holds, and incarcerations, and had been non-compliant with medications prescribed in jail.
Following aggressive episodes at CMHHIP — including slamming and breaking a door, yelling, and threatening posturing toward staff — hospital personnel began administering Zyprexa and Depakote on an emergency basis. A.F.H. showed marked improvement within days. The State then petitioned for a six-month order authorizing involuntary administration of Zyprexa, Depakote, and Haldol (as a backup), along with related lab monitoring.
At the evidentiary hearing, Dr. Pillai testified in support of all four elements required under People v. Medina, 705 P.2d 961 (Colo. 1985). A.F.H. testified in opposition, asserting he had no mental illness, preferred a vegan diet as treatment, and experienced side effects including lethargy, restlessness, and muscle pain. The district court credited Dr. Pillai’s testimony, found A.F.H.’s account of side effects unreliable, and issued the requested six-month involuntary medication order.
The Court’s Holding
The Colorado Court of Appeals affirmed the district court’s order. A.F.H. challenged only the fourth Medina element — whether his need for treatment was sufficiently compelling to override any bona fide and legitimate interest in refusing medication. The court assumed for purposes of analysis that A.F.H.’s reported side effects (including undisputed sedation) constituted a bona fide and legitimate basis for refusal, but held that Dr. Pillai’s testimony nonetheless provided ample clear and convincing evidence that treatment was compelled.
The court found the record supported the district court’s conclusion that A.F.H.’s prognosis without medication was so unfavorable — given escalating aggression, serious risk of harm to others at CMHHIP, and significant improvement on medication — that his interest in refusal had to yield to the State’s interests in preserving his health and protecting institutional safety. The court declined to reweigh the competing interests, deferring to the district court’s credibility determinations and resolution of conflicting evidence. It also declined to address A.F.H.’s challenge to approved medication dosages and his request to rebalance interests, both raised for the first time in his reply brief.
Key Takeaways
- Under People v. Medina, the State may obtain a court order for involuntary antipsychotic medication by proving four elements by clear and convincing evidence; a treating psychiatrist’s testimony alone can satisfy that standard.
- Even assuming a patient’s reported side effects constitute a bona fide and legitimate basis for refusing medication, a court may still authorize involuntary treatment if the prognosis without medication is sufficiently unfavorable and the patient poses a serious risk to others in the institution.
- Appellate courts defer to the district court’s credibility findings and resolution of conflicting evidence in involuntary medication proceedings; they will not reweigh the patient’s interests against those of the State on appeal.
- Arguments raised for the first time in a reply brief — including challenges to approved medication dosages — will not be considered on appeal.
Why It Matters
This unpublished decision illustrates how Colorado courts apply the Medina framework when a patient found incompetent to stand trial resists psychiatric medication based on claimed side effects. The opinion confirms that reported side effects, even if credited as bona fide, do not automatically defeat an involuntary medication order; what controls is the comparative weight of the patient’s deterioration and danger to others against the burdens of treatment.
The case also serves as a practical reminder for practitioners: arguments not raised before the district court or raised only in a reply brief are forfeited on appeal, including challenges to specific medication dosages. Counsel representing respondents in involuntary medication proceedings must present all objections fully at the trial-court level to preserve them for review.